INS and Glucose intolerance: However, SkM-specific overexpression of miR-17 resulted in a significant improvement in higher blood glucose (Figure 7E), glucose intolerance (Figure 7F), and insulin insensitivity (Figure 7G,H), and moreover, rescued the SkM from the suppression of insulin-stimulated pAkt and mGlut4 (Figure 7I).